Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Dividend Growth Predictions For 15 Companies Announcing Annual Boosts In October
07:23am, Monday, 02'nd Oct 2023
Fifteen long-term dividend growth companies, AbbVie among them, will announce their annual increases in October. Most of the increases will be in the single digit range, with 10%+ increases expected f
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
03:00pm, Saturday, 30'th Sep 2023
Clinical trials are a difficult and grueling process for companies. The FDA and other regulatory agencies require the highest possible standards in order to approve new drugs.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:31am, Friday, 29'th Sep 2023
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AbbVie's blood cancer combo therapy fails in late-stage study
08:05am, Friday, 29'th Sep 2023
AbbVie said on Friday a late-stage study of its experimental combination therapy failed to show meaningful increase in the survival of patients with a form of blood cancer without the disease worsenin
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
06:15am, Friday, 29'th Sep 2023
Diamondback's variable dividend offers even more upside potential from this red-hot oil stock. NextEra Energy Partners generates steady cash flows from its sizable renewable energy portfolio.
Don't Miss the Boom: 3 Biotech Stocks Set to Explode Higher
01:00pm, Tuesday, 26'th Sep 2023
In the dynamic investment realm, one sector that continues to stand out is the area of biotech stocks. Though risky, especially when assessing established firms with market-ready drugs and vast resear
AbbVie's (ABBV) Epcoritamab Gets Approval in Europe for DLBCL
12:01pm, Tuesday, 26'th Sep 2023
AbbVie ABBV and partner Genmab GMAB announced that the European Commission has granted conditional marketing authorization to epcoritamab for treating relapsed or refractory (R/R) diffuse large B-cell
AbbVie terminates deal with I-Mab to develop cancer drug
05:09pm, Friday, 22'nd Sep 2023
China-based biotech company I-Mab said on Friday that AbbVie has terminated a 2020 deal to co-develop and market I-Mab's lead cancer drug candidate lemzoparlimab.
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
01:54pm, Thursday, 21'st Sep 2023
AbbVie is entering a new era but is well prepared to return to its winning ways. Gilead Sciences offers investors steady and reliable performance and a great dividend.
Flee to Healthcare Stocks if Recession Rears its Head?
07:04am, Wednesday, 20'th Sep 2023
If you're looking for a sector that's on sale, look to healthcare. The Health Care Select Sector SPDR Fund NYSEARCA: XLV is down 2.50% in the past month, lagging the S&P 500.
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
11:36am, Tuesday, 19'th Sep 2023
Navigating the unpredictable waters of today's market, safe dividend stocks emerge as a beacon of reliability. Despite an optimistic kickoff this year, the broader market sentiment has chilled.
The Top 7 Underrated Dividend Stocks Yielding 3% or More
06:50am, Tuesday, 19'th Sep 2023
Looking for dividend stocks yielding 3% or more might seem pretty specific. Remember, though, the logic behind investing in underrated stocks is straightforward: Buy low and sell high in order to see
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:32am, Monday, 18'th Sep 2023
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths
01:02pm, Friday, 15'th Sep 2023
Currently, the S&P 500 and many sectors are outperforming the healthcare sector, presenting an opportunity to explore assets within this sector during the current period of apathy towards it. AstraZen
2 Dividend Kings to Buy on the Dip and Hold Forever
09:15am, Friday, 15'th Sep 2023
Abbott Laboratories and AbbVie used to be one and the same company. Both have raised their payouts for 51 years in a row, making them Dividend Kings.
